Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan J Little

Showing results (161-170 of 200) with videos related to

Pageof 20
Sort By:
AIDS (London, England)|October 21, 2006
Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacityJason D Barbour, Frederick M Hecht, Susan J Little, et al.
The Journal of Infectious Diseases|April 6, 2005
Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1Matthew C Strain, Susan J Little, Eric S Daar, et al.
AIDS (London, England)|March 25, 2024
Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapySara Gianella, Christy Anderson, Antoine Chaillon, et al.
Plos Pathogens|August 1, 2014
Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infectionEun-Young Kim, Ramon Lorenzo-Redondo, Susan J Little, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2009
Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infectionLinda G Apuzzo, Florin Vaida, Joel E Gallant, et al.
AIDS (London, England)|December 23, 2008
A public health model for the molecular surveillance of HIV transmission in San Diego, CaliforniaDavey M Smith, Susanne J May, Samantha Tweeten, et al.
AIDS (London, England)|July 26, 2016
Viral load criteria and threshold optimization to improve HIV incidence assay characteristicsReshma Kassanjee, Christopher D Pilcher, Michael P Busch, et al.
Scientific Reports|August 25, 2015
Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral TherapyMarta Massanella, Sara Gianella, Rachel Schrier, et al.
The New England Journal of Medicine|August 9, 2002
Antiretroviral-drug resistance among patients recently infected with HIVSusan J Little, Sarah Holte, Jean-Pierre Routy, et al.
Journal of Virology|February 14, 2004
Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infectionAndrew J Leigh Brown, Simon D W Frost, Benjamin Good, et al.
Pageof 20

Showing results (161-170 of 200) with videos related to

Sort By:
Pageof 20
AIDS (London, England)|October 21, 2006
Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacityJason D Barbour, Frederick M Hecht, Susan J Little, et al.
The Journal of Infectious Diseases|April 6, 2005
Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1Matthew C Strain, Susan J Little, Eric S Daar, et al.
AIDS (London, England)|March 25, 2024
Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapySara Gianella, Christy Anderson, Antoine Chaillon, et al.
Plos Pathogens|August 1, 2014
Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infectionEun-Young Kim, Ramon Lorenzo-Redondo, Susan J Little, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2009
Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infectionLinda G Apuzzo, Florin Vaida, Joel E Gallant, et al.
AIDS (London, England)|December 23, 2008
A public health model for the molecular surveillance of HIV transmission in San Diego, CaliforniaDavey M Smith, Susanne J May, Samantha Tweeten, et al.
AIDS (London, England)|July 26, 2016
Viral load criteria and threshold optimization to improve HIV incidence assay characteristicsReshma Kassanjee, Christopher D Pilcher, Michael P Busch, et al.
Scientific Reports|August 25, 2015
Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral TherapyMarta Massanella, Sara Gianella, Rachel Schrier, et al.
The New England Journal of Medicine|August 9, 2002
Antiretroviral-drug resistance among patients recently infected with HIVSusan J Little, Sarah Holte, Jean-Pierre Routy, et al.
Journal of Virology|February 14, 2004
Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infectionAndrew J Leigh Brown, Simon D W Frost, Benjamin Good, et al.
Pageof 20